HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Talisomycin B

HCID 102059865
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
65057-91-2
Standard SMILES
Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)CC(=O)N[C@H](C(=O)NC(O[C@@H]1O[C@@H](C)[C@@H](N)[C@@H](O)[C@H]1O)C(O)c1nc(-c2nc(C(=O)NCCCNCCCCN)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1cnc[nH]1
InChIKey
JBMBADLYKKSXRS-FUATYRKLSA-N
Molecular formula
C62H98N20O26S2
Average molar mass
1,603.7 g/mol
Monoisotopic mass
1,602.6402557

Names & identifiers

Preferred name
Talisomycin B
IUPAC
[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5S,6S)-2-[(1R,2S)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[(2R,3S)-5-[[(2S,3R)-1-[[2-[4-[4-[3-(4-aminobutylamino)propylcarbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]-1-[(2S,3R,4R,5S,6S)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy-2-hydroxyethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate
English name
N1-[3-[(4-Aminobutyl)amino]propyl]-13-[(4-amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-19-demethyl-12-hydroxybleomycinamide
Molecular formula
C62H98N20O26S2
Molecular weight
1603.69

Names & synonyms

Talisomycin BAntibiotic BU 2231BUNII-17LR410D8ATALLYSOMYCIN B [MI]Bleomycinamide, N(sup 1)-(3-((4-aminobutyl)amino)propyl)-13-((4-amino-4,6-dideoxy-alpha-L-talopyranosyl)oxy)-19-demethyl-12-hydroxy-BLEOMYCINAMIDE, N1-(3-((4-AMINOBUTYL)AMINO)PROPYL)-13-((4-AMINO-4,6-DIDEOXY-.ALPHA.-L-TALOPYRANOSYL)OXY)-19-DEMETHYL-12-HYDROXY-N1-(3-((4-AMINOBUTYL)AMINO)PROPYL)-13-((4-AMINO-4,6-DIDEOXY-.ALPHA. -L-TALOPYRANOSYL)OXY)-19-DEMETHYL-12-HYDROXYBLEOMYCINAMIDEBU-2231BTallysomycin BAntibiotic BU-2231BN1-[3-[(4-Aminobutyl)amino]propyl]-13-[(4-amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-19-demethyl-12-hydroxybleomycinamideBleomycinamide, N1-[3-[(4-aminobutyl)amino]propyl]-13-[(4-amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-19-demethyl-12-hydroxy-

Database identifiers

Properties

Computed structural propertiesFilling in

XLogP
-12.4
Topological polar surface area
827 Ų
Hydrogen bond donors
26
Hydrogen bond acceptors
39
Rotatable bonds
42
Heavy atoms
110
Formal charge
0
Complexity
2,970

Physicochemical properties

alpha
23 · D23 -19° (c = 0.5 in water)
Density
1.0979 · 1.0979 (rough estimate)
refractive index
1.67 · 1.6700 (estimate)
FDA UNII
17 LR410D8A · 17LR410D8A
Toxicity
50 s.c · LD50 s.c. in mice: >50 mg/kg (US 4051237)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Toxicity
LD50 s.c. in mice: >50 mg/kg (US 4051237)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationRelated reactionsCompound notes
CAS
65057-91-2
PubChem CID
102059865
UNII
17LR410D8A
Nikkaji
J34.313G